Vol. 166, No. 3, 1990 February 14, 1990
BIOCHEMICAL
AND BIOPHYSICAL RESEARCH COMMUNICATIONS Pages 1205-1212
ACIDIC AND BASIC FIBROBLAST
EXPRESSED
BY SKELETAL
GROWTH FACTOR mRNAS ARE!
MIJSCLE
SATELLITE
CELLS
JeanineAlterio*, Yves Courtois*,JacquesRobelin**, DanielBechet**and IsabelleMarte:lly*** 1 *Unit6 deRechercheGerontologique no118INSERM, meWhilhemParis75016,France ** INRA, 63122Ceyrat,France ***LaboratoiredeMyog6neseet RCgt%r&ation Musculaire(MYREM), Universid ParisVal deMame,av G6nCraldeGaulle,Cr6teil94010 , France Received
December
19,
1989
SUMMARY:
We postulated that Fibroblast Growth Factor (FGF) involved in fetal or regenerative morphogenesis of skeletal muscle originated from this tissue. Using a bovine retina cDNA probe encoding acidic :FGF, we showed that growing muscles from bovine fetuses express this mRNA, but that this expression is reduced in neonate muscles. Cultures of proliferating satellite cells isolated from adult rat muscles expressed aFGF mRNA strongly but bFGF mRNA weakly: these mRNAs disappeared in cells differentiated into myotubes. 10-7M 12-0-tetradecanoyl phorbol -13-acetate (TPA) increased aFGF mRNA expression in both proliferating and differentiated satellite cells. Contrastingly, proliferating L6 myogenic cells only expressed aFGF mRNA significantly under TPA treatment. Therefore, the satellite cells did seem to be a possible source for FGF, especially aFGF, which might regulate the myogenic process. QI.990Academic Press,Inc.
The proliferation of mesodermic tissue is known to be regulated by FGF , especially bFGF.
In vitro , a- and bFGF where observed to stimulate cellular in primary cultures of myoblasts and myogenic cell lines (see review 1). Furthermore, FGF is also known to inhibit the myogenic differentiation of embryonic myoblasts and myogenic cell lines (2.3) and of rat satellite cells (4).
proliferation
The addition of FGF to cells at the postmitotic expression
(5)
and their
content
of
the
stage induced reductions of mRNA specific
muscle protein
creatine
phosphokinase (CPK) (6). In adult animals, skeletal muscles regenerate through the activation of undifferentiated
myogenic cells called satellite cells (7), which proliferate
and
differentiate into myotubes in vitro, in the same way as do fetal myoblasts. Satellite cell proliferation is stimulated by FGF (4.8, and our observation). In mdx mouse mutants, whose muscles are continuously regenerating, bFGF was detected *To whom reprint
requests
should
be addressed. 0006-291X/90 1205
$1.50
Copyright 0 1990 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
166, No. 3, 1990
BIOCHEMICAL
AND BIOPHYSICAL
in basal membranes of muscle fibers at a normal non dystrophic
RESEARCH COMMUNICATIONS
much higher concentration than in
muscles (9).
These results show the key role of FGF in regulating growth and the morphogenesisof mesodermic-derived tissue such as skeletal muscle. The origin of this growth factor, found principally in the extracellular matrix of growing or regenerating muscles (9). is widely misunderstood. In this study, we postulated that myogenic cells
generate
such growth factors, at least in part. We therefore examined developing muscles and cultured myogenic cells to see if they were capable of transcribing genes encoding FGF. EXPERIMENTAL
PROCEDURES
Bovine muscle RNA preparation: Four muscles, longissimus dorsii (LD) , tensor faciae latae (TFL), masseter (M) and rectus abdominis (RA),were taken from bovine fetuses aged 103,152 and 250 days, and from newborn animals. Total guanidinum-LiCl procedure of RNA was isolated by a modified version of the Chigwin et al. (10). Cell cultures: Satellite cells were prepared as previously described (1 l), with the following modifications: rat satellite cells were dissociated from muscle fibers by incubation for 2 hrs at 37°C in 0.15% pronase in Ham’s F12 medium buffered with 1OmM HEPES. After exhaustive washing, satellite cells suspended in Dulbecco Modified Medium containing 10% fetal calf serum and 10% horse serum (Gibco were seeded on gelatinized petri dishes at the concentration of 2~10~ cells per cm1 and incubated in 5% CO2 at 37°C. The L6 cell line was grown as described previously (11). In some experiments, O.luM of the phorbol ester 12-0-tetradecanoylphorbol 13-acetate (TPA, Sigma) was added to cultures for 2 to 24hrs. The drug was prepared in DMSO (Merck) and the final concentration of the solvent represented 0.01% in TPA-treated cultures. The same DMSO concentration was added to control cultures. DNA synthesis was measured on 4 different cultures after a 6 hr incubation with 0.2 uCi /ml of methyl-3H-Thymidine (87Ci/mmol, Amersham). Cultures were dissolved in 0.5M NaOH. Incorporated radioactivity was determined by liquid scintillation counting. Proteins were determined according to Lowry in aliquots of the same samples. Under our experimental conditions, the soluble 3H-Thymidine which was not incorporated into DNA constituted 10% of total radioactivity. The activity of creatine phosphokinase (CPK) was measured with a Merckotest kit (Merck). Cells were lysed in 50mM Tris HCl pH 7.5, and 1mM phenyl methyl sulfonyl fluoride (Sigma), and extracts were sonicated before the assays. Endogenous myokinase was inhibited by the addition of 3mM Ap5A:pl,p5-Di(adenosine-5’)pentaphosphate (Sigma). Each point represent 3 separate measurements. Cellular mRNA isolation: Satellite cells were lysed during proliferation or differentiation into myotubes, in buffer containing 4M guanidinum isothyocyanate, 1M l3-mercaptoethanol and 0.5% Sarkosyl. Total RNA was isolated by ultracentrifugation on a CsCl cushion according to standard procedure (12). Poly (A+) mRNAs were purified by affinity chromatography on Hybound-Map (Amersham) according to supplier’ s instructions. Probes: The Acidic FGF cDNA probe is a 4.0 Kb bovine aFGF cDNA cloned into lambda gtll (13). The cDNA insert, which sequence contained the entire protein coding sequencefor bovine aFGF (14). The basic FGF cDNA probe was a gift from J. Abraham and J. Fiddes (California Biotechnology Inc. Mountain View, CA). This probe was a 1.4 Kb bovine bFGF cDNA cloned into pBR 322 (15). The cDNA insert contained the entire protein coding sequence for bovine bFGF. The (GAPDH) obtained from glyceraldehyde-3-phosphate dehydrogenase cDNA probe 1206
Vol.
BIOCHEMICAL
166, No. 3, 1990
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
Dr. Blanchard (Depart. Molec. Biol., Montpellier Univ., France) was a 1.3 Kb rat GAPDH cDNA cloned into PUC 18 (16). This probe was used as internal standard and also to estimate the loading and transfer efficiency of RNA samples. Northern Blot analysis: Northern blot of Poly (A+) mRNA purified from satellite cells was prepared as previously described (13) except that RNA was transferred onto Genescreen Plus membrane (DuPont de Nemours, France). The RNA blot was prehybridized at 42’C in a buffer containing 50% formamide. 1% SDS, 1M NaCl, 10% dextran sulfate and lOOug/ml salmon DNA. Blot was then incubated in the same buffer at 42°C with specific probes labeled with 32P by nick translation ( lo6 cpm/ml). The blots were washed twice for 20 min in 2xSSC at 60°C and processed by autoradiography. Dot blot analysis: Total RNAs extracted from bovine skeletal muscles or Poly(A+) mRNA from rat satellite cells were dissolved in a buffer containing 50% deionized formamide and 6% formaldehyde. Genescreen Plus membranes were loaded, either with 4ug mRNA prepared from satellite cell cultures, or with 2 to 0.25 ug of total RNA extracted from bovine muscles. The exact quantity of RNA loaded onto the membranes was measured by reflection-absorption at 260nm using a Shimadzu scanning densitometer. The RNAs were hybridized as for Northern blot analysis . After hybridization with a specific probe, the blots were washed twice for 20 min in 1xSSC at 42’C for bovine muscle RNAs, and in 2xSSC at 60°C for satellite cell mRNAs . The membranes were then subjected to autoradiography. RESULTSAND DISCUSSION When dot
blots
of RNA extracted from four
muscles of bovine fetuses of
different ages were analyzed with a aFGF cDNA probe (Fig l), aFGF mRNA was abundant in Longissimus dorsii. detected in all four muscles and was especially The strength of its hybridization signal diminished during fetal development and was almost undetectable in neonate muscles. As the amount of RNA loaded onto membranes was UV-controlled, fetal
development
the
was significant.
The
diminution reason
1234
A
B
of why
the
hybridization
signal
1234
a b c d
it C d
a b C
it C
d
d
-1:
C
D
Dot blot analysis of poly(A+) mRNA extracted from fetal and newborn bovine skeletal muscles. Total RNAs extracted from fetal muscles (A: 103 days; B : 152 days and C: 250 days) ‘or from newborn skeletal muscles (D) were analysed by dot blot, as described in Experimental Procedures; to detect acidic FGF gene transcripts, 2ug (1). lug (2). 0.5ug (3) and 0.25ug (4) total RNA purified from (a) longissimusdorsii, (b) tensor faciae latae, (c) masseter and (d) rectus abdominis were hybridized with aFGF cDNA aa probe . 1207
during
aFGF mRNA was present for a
Vol. 166, No. 3,
BIOCHEMICAL
1990
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
3H Thymidine pmol Img prot 400
-
300
--
200
--
100
.-
10-2
CPK x U/mg
prot
+0 0
4
2
6
6 days
of
10
12
14
culture
Fig. 2 ; Determination of proliferation and differentiation stages of rat satellite cells in culture. The rate of DNA synthesis was determinedby
measuring 3H-Thymidine incorporation into cells after 6 hr incubation and creatine phosphokinase(CPK) was estimatedin cell extracts at different times after plating, as describedin Experimental Procedures.
longer time in Longissimus dorsii fetal skeletal musclesdo To facilitate
is not known. This result proved, however, that
express aFGF mRNA, especially during
growth .
the study of FGF mRNA expression during the myogenic
process, we used primary cultures of rat satellite cells, which in vitro mimic fetal myogenesis in vivo. Under our standard culture conditions (fig 2). satellite cells in primary cultures proliferated during the first 6 days after plating. 3H-Thymidine incorporation into DNA was maximal at the 4th day of culture. This agrees with the After the proliferative period, data we obtained earlier by image analysis (17). cellular differentiation
commenced
and
fusion took place,
leading to the
formation of myotubes which contracted spontaneously on the 12th day of culture. Differentiation
of
cultures
was routinely
recorded
by
the
appearance of
muscle-specific gene products such as CPK. As a function of these results, RNAs were extracts on the 4th and 14th days of culture. They will be referred to below as proliferating cell and myotube RNAs respectively. Messenger RNAs were analyzed by Northern blot hybridization, with cDNA of
retina bovine aFGF and brain bovine bFGF as probes (Fig 3). The presence of a single aFGF mRNA species was shown in lane A3, where 1Oug mRNA from proliferating cells was applied to the blot (fig 3-A). The hybridization band for satellite cell extracts correspondedto 4.0 Kb, as the aFGF mRNA found in bovine retina (lane A2). An additional 2.5 Kb mRNA was detected in bovine retina, and its characterization is presently under investigation. On the other hand, no hybridization signal was detectable with mRNA prepared from myotubes (lane A4) in spite of the increased quantity of mRNA
applied (14 vs 10 ug).
1208
Vol.
BIOCHEMICAL
166, No. 3, 1990 Under
3-A),
bFGF
labeled
same
conditions
cDNA
probe
was applied
band
corresponded retina
was (lane
the bFGF
of
reflected
from
(lane
the amount
B3). of
of mRNA
firstly,
mRNA
when
they
proliferate,
rat brain
The aFGF cultures (20). RNA
mRNA
of cardiac
As internal
onto
with
membrane
but
of satellite
rmt
did
control,
GAPDH 3
they
not
(18),
intensity
of the hybridization
from
satellite
cells
was
lowfer
signal than
have
A
obtained
with
they mutase
that the probe
).
of F9 teratocarcinoma
The
cultures
do express
differentiated cells with
into
as that of
(19)
and of 10 ug of
4 ug of bovine
6
1234
123
f
GAPDH Ejz. 3 : Nothern blot analysis of poly(A+) mRNA purified from in proliferating rat satellite cells culture, and from ceils into myotubes. mRNAs derived from differentiated Polyadenylated proliferating cells (A3 and B2, 10 ug) and from myotubes (A4 and B3, 14ug). and poly(A+) mRNA extracted from bovine retina (A2 and Bl, 5 ug) used as control, were analyzed by Northern blot, as described in Experimental Procedures. RNAs were sucessively hybridized with aPGF (A) and bFGF (B) cDNA probes. To determine the relative amounts of RNA loaded per lane, blots were rehybridized with a GAPDH plasmid probe. The sizes of the 32P-labeled Hind III restriction fragments of Lambda DNA (Al) are indicated. 1209
It
hybridize
cDNA
cells is about the same size (4.OKb)
myocytes
B2).
we showed
in primary
once
(lane
the 7.0 Kb of bovine
phosphoglycerate
the
(Fig
A faintly
set of experiments
of
(Fig
cells
above
3-B).
extracts
cultures
form
that satellite
(fig
from
in another
muscular obtained
loaded
prove
myotubes.
However,
the
signal
results
cell
differentiated
described
blot
was different
in preparation).
hybridization
as those
proliferating
Extracts mRNA
RESEARCH COMMUNICATIONS
to the same Northern
with
These
primary poly(A+)
the
hybridization
Kb which
probe the
et al, manuscript
intensity
aFGF
with
of
of 6.0
Bl).
cDNA
hybridize
(Castella
detectable
to an mRNA
mRNA
with did
the
AND BIOPHYSICAL
retina
Vol.
BIOCHEMICAL
166, No. 3, 1990
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
mRNA. According to Goodrich, there is a 90% homology between bovine and rat aFGF cDNA (21). Thus, the fact that less of the bovine cDNA probe was hybridized with rat myogenic mRNA than with bovine retina mRNA might only mean that less aFGF messenger was present in satellite cells. Secondly, our results show that the expressionof bFGF mRNA was only weak in proliferating satellite cells. A 6.0 Kb mRNA species was found in extracts of these cells as in rat brain (22). Whereas a single 7.OKb bFGF mRNA species was found in bovine retina , two distinct mRNA speciesof 7.0 and 3.7 Kb encoded bFGF in bovine brain (15) and capillary cells (23), and several mRNA species were detected in human cells (24,25). In addition, in cells which had differentiated into myotubes, aFGF and bFGF mRNAs disappeared, suggesting that FGF mRNA was down-regulated during the myogenic process. Contaminating non myogenic cells, presumably fibroblasts. which are unavoidable in satellite cell primary cultures, accounted for
about 10% of the total number of cells which we previously
determined under clonal
culture conditions
(17).
Here, however,
despite the presence of a few fibroblasts which might have produced FGF (24,25.26), it is highly improbable that these contaminating cells, which would no doubt be present in both growing and differentiated cultures, participated significantly in aFGF mRNA expression, because it was confined to proliferating cultures and was not detectable in differentiated cultures. The absence of FGF mRNA in myotube cultures raises the possibility of a causal relationship between proliferation ability and the presence of FGF mRNA, since addition of exogenous FGF is known to keep cells in the proliferation cycle and delay differentiation
(see review l), and since FGF receptors are also known to disappear during myogenesis (27). Several studies have shown that protein kinase C activators such as the phorbol ester TPA alter the expression of various growth factors (28) including bFGF (29.30). We therefore TPA
on aFGF mRNA
concentration
of TPA
investigated the effect of
10s7M expression in growing and differentiated satellite cells. This was chosen because it partially inhibits the proliferation of in preparation). Dot blot analyses of poly(A+) RNA from
satellite cells (Martelly satellite cells treated with TPA or from untreated cells
were performed with
the aFGF bovine cDNA as a probe (fig 4). After 24h of TPA treatment, the level of hybridization in extracts of growing cells rose (fig 4-Al and A2). TPA also induced the expression of aFGF mRNA in differentiated cultures (fig 4-B). The hybridization signal of poly(A+) RNA prepared from the myogenic cell line L6 (fig 4-C) was very weak in proliferating untreated satellite cells (fig 4-Cl) and increased in TPA-treated cells with the duration of treatment. Therefore aFGF mRNA appeared to be positively regulated by TPA. These results also proved that a persistent state of proliferation was not required for aFGF mRNA expression, as TPA treatment increased FGF mRNA expression, not only in proliferating cultures (despite a 40% reduction of proliferation), but also in non-proliferating myotube cultures.
Consequently, the proliferative
capacity
1210
of
myogenic cells
did not
Vol.
BIOCHEMICAL
166, No. 3, 1990
AND BIOPHYSICAL
RESEARCH COMMUNICATIONS
Fig. 4 : Dot blot analysis of RNAs extracted from poly(A+) proliferating cells or cells differentiated into myotubes in culture either treated with 1O“M TPA or not treated. Dot blots were analysed for the presence of aFGF mRNA gene trancripts in 4ug poly(A+) mRNA from each of the following: proliferating satellite cells, either not treated (Al), or treated with TPA for 24h (A2); satellite cells differentiated into myotubes, either not treated (Bl), or treated with TPA for 24h(B2); proliferating L6 cells, untreated (Cl), or treated with TPA for either 2h (C2) or 6h (C3). Poly (A+) RNA purified from bovine retina (D) was used as internal control.
necessarily
correlate
underlined
by
significantly
this L6
the
when
the level
with fact
that
stimulated
of aFGF mRNA
proliferating by TPA.
L6 However,
myogenic cell line displayed
cells
expression.
only
expressed
This FGF
was mRNA
compared to other myogenic cells,
several differences including level of
protein kinase C (21), certain L6 sublines did not respond to exogenous FGF stimulation, and differ in their “spare”
receptors for insulin growth factors I and
II (31) and for FGF (Olwin B.B. and HauschkaS.D. unpublishedresults cited in 3, 32 and our personal observations). Here, L6 cells did not express FGF mRNA at the proliferating stage, unlike the satellite cells. In conclusion, we showed that aFGF mRNA was more
strongly expressed
than bFGF mRNA by proliferating satellite cells before their differentiation myotubes. In the satellite cells,
into
the presence of aFGF mRNA coincided with that of
aFGF protein. About 10 times more aFGF was found in 4 day proliferating satellite cell cultures, than in satellite cells which had only just dissociated from muscle or which
had
differentiated
into
myotubes
(Groux-Muscatelli
personal
communication). It was rather surprising to find that myogenic cells synthetized more aFGF mRNA than bFGF mRNA. Acidic FGF with is less ubiquitous than bFGF, was generally found in the nervous system including photoreceptors (33), and more and recently in fibroblasts (26) , cardiac myocytes (34) kidney cells (35) smooth
muscle
aFGF
in muscle
aFGF,
as well
cells
(26).
In addition,
extracellular as bFGF,
However,
matrix. might
bFGF
has more
often
been
detected
than
the present findings suggest that
play a role in myogenesis, possibily through
autocrine action. ACKNOWLEDGMENTS: We wish
to thank
This study was partially C. Rey for
culturing
satellite 1211
supported cells,
Drs
by INSERM J. Abraham
(N0876015). and J.M.
Vol.
166, No. 3, 1990
Blanchard Dreyfus
for for
BIOCHEMICAL
supplying revising
respectively
the english
AND BIOPHYSICAL RESEARCH COMMUNICATIONS
the bFGF
editing
and
GAPDH
cDNA
probes,
and
M.
.
REFERENCES
1 - Florini J.R. and Magri K.A. (1989) Am. J. Physiol 256, C701-711. 2- Linkhart T.A., Clegg C.H. and HauschkaS.D. (1981) Dev. Biol. 86,19-30. 3- Clegg C.H., Linkhart T.A. Olwin B.B. and HauschkaS.D. (1987) J. Cell Biol. 105, 949-956. 4- Allen R.E., Dodson M.V. and Luiten L.S. (1984) 152,154-160. S- Spizz G., Roman D., Strauss A. and Olson E.A. (1986) L. Biol. Chem. 261,9483-9488. 6 - Lathrop B., ThomasK. and Glaser L. (1985) J. Cell. Biol 101,2194-2198. 7- Mauro A. (1961) J. Biophys. Biochem Cytol. 9,493-49X 8- Allen R.E., Dodson M.V., Luiten L.S. and Boxhom L.K. (1985) In vitro 21,636-)640. 9- Di Mario J., Biffinger N., Yamada S. ans Strohman R.C. (1989) Science 244,688-690. lo- Chirgwin J.M., Przybyla A.E., MC Donald R.J. and Rutter W.J. (1979) Biochemistry 18:5294-5299. ll- Martelly I., Gautron J. and Moraczewski J. (1989) Exp. Cell Res. 183.92-100. 12- Glisin V., Czkvenjakov R. and Byus C. (1974) Biochemistry 13,2633-2637.2513- Alterio J., Halley C., Brou C., SoussiT., Courtois Y. and laurent M. (1988) Febs Letters 242,41-46. 14- Halley C., Courtois Y and Laurent M. (1988) Nucl. Acid Res. 16 (22), 10913 15- Abraham J., Mergia A., Whang J.L. Tumolo A., Friedman J. , Hjerrild K.A., Gospodarowicz D. and Fiddes J. (1986) Science 233, 545-548. 16- Fort P., Marty L., Piehaczyk M. Sabrouty S., Dani C., Jeanteur P. and Blanchard J.M. (1985) Nucl. Acid. Res . 13,1434-1442. 17- Lassalle B., Gautron J., Martelly I. and Le Moigne A. (1989) Cytotechnology, 2,213-22 18- Weiner H.L. and Swain J.L. (1989) Proc. Nat. Acad. Sci. USA 86,2683-2687. 19- Braunhut S.J., Gudas L.J., Kurokawa T., SasseJ.and D’Amore P.A. (1989) J. Cell. Biol. 108, 2467-2476. 20- Logan A. (1988) Molec. Cell. Endocrinol. 58, 275-278. 21- Goodrich S.P., Yan G.C., Bahrenburg K. and Mansson P.E. (1989) Nucleic Acid Res. 17(7) 2867. 22- SchimasakiS., Emoto N., Koba A., Mercado M., Shibata F., Cooksey K., Baird A. and Ling N. (1988) Biochem. Biophys. Res. Commun. 157(l), 256-263. 23- Schweigerer L., Neufeld G., Friedman J. , Abraham J.A., Fiddes J.C. and Gospodarowicz D. (1987) Nature 325.257-259. 24- Kurokawa T., SasadaR., Iwane M. and Igarashi K (1987) Febs Letters 213(1)189-19, 25- Stemfeld M.D., Hendrickson J.E., Keeble W.W., Rosenbaum J.T., Robertson J.E., Pittelkow M.R. and Chipley G.B. (1988) J. Cell. Physiol. 136.297-304. 26-Winkles J., Friesel R., Burgess W.H., Howk R. , Mehlman T., Weinstein R. and Maciag T. (1987) Proc. Nat. Acad. Sci. USA 84.7124-7128. 27- Olwin B.B. and HauschkaS. (1988) J. Cell. Biol. 107,761-769. 28- Martelly I. and CastagnaM. (1989) Current Opinion in Cell Biol. 1,206-210. 29- Murphy P.R., Sato Y, Sato R. and Friesen H.G. (1988) Molec Endocrinol. 2,1196-1201. 30- Bikfalvi A., Dupuy E., Inyang A.L., Fayen N., Leseche G., Courtois Y. and Tobelem G. (1989) Exp. Eye Res. 181,75-84. 31- Beguino F., Kuhn C.P. , Moses A.C. and Smith R.J. (1985) J. Biol. Chem. 260,15892-15898. 32 -Florini J. R., Ewton D.Z., Falen S.L. and Van Wyk J.J. (1986) Am. J. Physiol 25O,C771-778. 33- Plot& J., Mascarelli F., Loret M.D. , Faure J.P. and Courtois Y. (1988), Embo J. 7(2),373-376. 34- Gautschi-Sova P., Jiang Z.P. Schroder M. and Bohlen P. (1987) Biochemistry 26, 58445847. 35- Wang W.P., Lehtoma K., Varban M.L., Krishman I. and Chiu I.M. (1989) Molec. Cell. Biol. 9(6), 2387-2395. 1212